FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2430361330> ?p ?o ?g. }

• W2430361330 endingPage "212" @default.
• W2430361330 startingPage "204" @default.
• W2430361330 abstract "In recent years, it has become evident that Parkinson's disease is associated with a self-sustaining cycle of neuroinflammation and neurodegeneration, with dying neurons activating microglia, which, once activated, can release several factors that kill further neurons. One emerging pharmacological target that has the potential to break this cycle is the microglial CB2 receptor which, when activated, can suppress microglial activity and reduce their neurotoxicity. However, very little is known about CB2 receptor expression in animal models of Parkinson's disease which is essential for valid preclinical assessment of the anti-Parkinsonian efficacy of drugs targeting the CB2 receptor. Therefore, the aim of this study was to investigate and compare the changes that occur in CB2 receptor expression in environmental and inflammation-driven models of Parkinson's disease. To do so, male Sprague Dawley rats were given unilateral, intra-striatal injections of the Parkinson's disease-associated agricultural pesticide, rotenone, or the viral-like inflammagen, polyinosinic:polycytidylic acid (Poly (I:C)). Animals underwent behavioural testing for motor dysfunction on days 7, 14 and 28 post-surgery, and were sacrificed on days 1, 4, 14 and 28. Changes in the endocannabinoid system and neuroinflamamtion were investigated by qRT-PCR, liquid chromatography-mass spectrometry and immunohistochemistry. After injection of rotenone or Poly (I:C) into the rat striatum, we found that expression of the CB2 receptor was significantly elevated in both models, and that this increase correlated significantly with an increase in microglial activation in the rotenone model. Interestingly, the increase in CB2 receptor expression in the inflammation-driven Poly (I:C) model was significantly more pronounced than that in the neurotoxic rotenone model. Thus, this study has shown that CB2 receptor expression is dysregulated in animal models of Parkinson's disease, and has also revealed significant differences in the level of dysregulation between the models themselves. This study indicates that these models may be useful for further investigation of the CB2 receptor as a target for anti-inflammatory disease modification in Parkinson's disease." @default.
• W2430361330 created "2016-06-24" @default.
• W2430361330 creator A5022841772 @default.
• W2430361330 creator A5030416041 @default.
• W2430361330 creator A5056496101 @default.
• W2430361330 creator A5057611378 @default.
• W2430361330 date "2016-09-01" @default.
• W2430361330 modified "2023-10-01" @default.
• W2430361330 title "Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation-driven rat models of Parkinson's disease" @default.
• W2430361330 cites W1484568938 @default.
• W2430361330 cites W1503696655 @default.
• W2430361330 cites W1542528083 @default.
• W2430361330 cites W1594710133 @default.
• W2430361330 cites W1602148483 @default.
• W2430361330 cites W1604823664 @default.
• W2430361330 cites W1678465678 @default.
• W2430361330 cites W1929488495 @default.
• W2430361330 cites W1965712628 @default.
• W2430361330 cites W1967127565 @default.
• W2430361330 cites W1975774284 @default.
• W2430361330 cites W1986854935 @default.
• W2430361330 cites W1987183038 @default.
• W2430361330 cites W1991497324 @default.
• W2430361330 cites W1996506764 @default.
• W2430361330 cites W2000076301 @default.
• W2430361330 cites W2001421590 @default.
• W2430361330 cites W2004579527 @default.
• W2430361330 cites W2007575448 @default.
• W2430361330 cites W2017876495 @default.
• W2430361330 cites W2020905741 @default.
• W2430361330 cites W2020978550 @default.
• W2430361330 cites W2021899761 @default.
• W2430361330 cites W2024782047 @default.
• W2430361330 cites W2025957614 @default.
• W2430361330 cites W2032715817 @default.
• W2430361330 cites W2038487696 @default.
• W2430361330 cites W2038636807 @default.
• W2430361330 cites W2040759534 @default.
• W2430361330 cites W2045837603 @default.
• W2430361330 cites W2050593289 @default.
• W2430361330 cites W2056730473 @default.
• W2430361330 cites W2058653418 @default.
• W2430361330 cites W2060414412 @default.
• W2430361330 cites W2064209015 @default.
• W2430361330 cites W2065375414 @default.
• W2430361330 cites W2073351779 @default.
• W2430361330 cites W2076009173 @default.
• W2430361330 cites W2076834233 @default.
• W2430361330 cites W2080185710 @default.
• W2430361330 cites W2095241201 @default.
• W2430361330 cites W2103247095 @default.
• W2430361330 cites W2103477492 @default.
• W2430361330 cites W2103707532 @default.
• W2430361330 cites W2111464898 @default.
• W2430361330 cites W2146663965 @default.
• W2430361330 cites W2147818403 @default.
• W2430361330 cites W2158248179 @default.
• W2430361330 cites W2163150813 @default.
• W2430361330 cites W2166408412 @default.
• W2430361330 cites W2166496419 @default.
• W2430361330 cites W2169788168 @default.
• W2430361330 doi "https://doi.org/10.1016/j.expneurol.2016.06.014" @default.
• W2430361330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27317300" @default.
• W2430361330 hasPublicationYear "2016" @default.
• W2430361330 type Work @default.
• W2430361330 sameAs 2430361330 @default.
• W2430361330 citedByCount "42" @default.
• W2430361330 countsByYear W24303613302016 @default.
• W2430361330 countsByYear W24303613302017 @default.
• W2430361330 countsByYear W24303613302018 @default.
• W2430361330 countsByYear W24303613302019 @default.
• W2430361330 countsByYear W24303613302020 @default.
• W2430361330 countsByYear W24303613302021 @default.
• W2430361330 countsByYear W24303613302022 @default.
• W2430361330 countsByYear W24303613302023 @default.
• W2430361330 crossrefType "journal-article" @default.
• W2430361330 hasAuthorship W2430361330A5022841772 @default.
• W2430361330 hasAuthorship W2430361330A5030416041 @default.
• W2430361330 hasAuthorship W2430361330A5056496101 @default.
• W2430361330 hasAuthorship W2430361330A5057611378 @default.
• W2430361330 hasConcept C104317684 @default.
• W2430361330 hasConcept C126322002 @default.
• W2430361330 hasConcept C127561419 @default.
• W2430361330 hasConcept C148001335 @default.
• W2430361330 hasConcept C170493617 @default.
• W2430361330 hasConcept C2776914184 @default.
• W2430361330 hasConcept C2776925932 @default.
• W2430361330 hasConcept C2778389096 @default.
• W2430361330 hasConcept C2778938600 @default.
• W2430361330 hasConcept C2779134260 @default.
• W2430361330 hasConcept C2779491297 @default.
• W2430361330 hasConcept C2779734285 @default.
• W2430361330 hasConcept C2779830541 @default.
• W2430361330 hasConcept C2780062018 @default.
• W2430361330 hasConcept C2780871563 @default.
• W2430361330 hasConcept C28859421 @default.
• W2430361330 hasConcept C29730261 @default.
• W2430361330 hasConcept C46721173 @default.

• next